Market Research Logo

Europe Chronic Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017

Europe Chronic Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Chronic Myeloid Leukemia patients study in a new report ‘Europe Chronic Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Chronic Myeloid Leukemia epidemiology, Chronic Myeloid Leukemia diagnosed patients, and Chronic Myeloid Leukemia treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Chronic Myeloid Leukemia derived from epidemiological analysis, percentage of patients diagnosed with Chronic Myeloid Leukemia, and percentage of patients treated with a therapy.

The study helps executives estimate Chronic Myeloid Leukemia market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Chronic Myeloid Leukemia prevalence, Chronic Myeloid Leukemia diagnosis rate, and Chronic Myeloid Leukemia treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Chronic Myeloid Leukemia Patient Flow
  • Chronic Myeloid Leukemia Prevalence
  • Chronic Myeloid Leukemia Diagnosed Patients
  • Chronic Myeloid Leukemia Treated Patients


1. Chronic Myeloid Leukemia: Disease Definition
2. Chronic Myeloid Leukemia Patient Flow in Europe
2A. Chronic Myeloid Leukemia Prevalence in Europe
2B. Chronic Myeloid Leukemia Diagnosed Patients in Europe
2C. Chronic Myeloid Leukemia Treated Patients in Europe
3. Chronic Myeloid Leukemia Patient Flow in Germany
3A. Chronic Myeloid Leukemia Prevalence in Germany
3B. Chronic Myeloid Leukemia Diagnosed Patients in Germany
3C. Chronic Myeloid Leukemia Treated Patients in Germany
4. Chronic Myeloid Leukemia Patient Flow in France
4A. Chronic Myeloid Leukemia Prevalence in France
4B. Chronic Myeloid Leukemia Diagnosed Patients in France
4C. Chronic Myeloid Leukemia Treated Patients in France
5. Chronic Myeloid Leukemia Patient Flow in Spain
5A. Chronic Myeloid Leukemia Prevalence in Spain
5B. Chronic Myeloid Leukemia Diagnosed Patients in Spain
5C. Chronic Myeloid Leukemia Treated Patients in Spain
6. Chronic Myeloid Leukemia Patient Flow in Italy
6A. Chronic Myeloid Leukemia Prevalence in Italy
6B. Chronic Myeloid Leukemia Diagnosed Patients in Italy
6C. Chronic Myeloid Leukemia Treated Patients in Italy
7. Chronic Myeloid Leukemia Patient Flow in UK
7A. Chronic Myeloid Leukemia Prevalence in UK
7B. Chronic Myeloid Leukemia Diagnosed Patients in UK
7C. Chronic Myeloid Leukemia Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Chronic Myeloid Leukemia Patient Flow in Europe, 2016
Table 2: Chronic Myeloid Leukemia Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Chronic Myeloid Leukemia Patient Flow in Germany, 2016
Table 4: Chronic Myeloid Leukemia Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Chronic Myeloid Leukemia Patient Flow in France, 2016
Table 6: Chronic Myeloid Leukemia Patient Flow Forecast in France, 2016 - 2025
Table 7: Chronic Myeloid Leukemia Patient Flow in Spain, 2016
Table 8: Chronic Myeloid Leukemia Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Chronic Myeloid Leukemia Patient Flow in Italy, 2016
Table 10: Chronic Myeloid Leukemia Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Chronic Myeloid Leukemia Patient Flow in UK, 2016
Table 12: Chronic Myeloid Leukemia Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Chronic Myeloid Leukemia Patient Flow in Europe, 2016
Figure 2: Chronic Myeloid Leukemia Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Chronic Myeloid Leukemia Patient Flow in Germany, 2016
Figure 4: Chronic Myeloid Leukemia Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Chronic Myeloid Leukemia Patient Flow in France, 2016
Figure 6: Chronic Myeloid Leukemia Patient Flow Forecast in France, 2016 - 2025
Figure 7: Chronic Myeloid Leukemia Patient Flow in Spain, 2016
Figure 8: Chronic Myeloid Leukemia Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Chronic Myeloid Leukemia Patient Flow in Italy, 2016
Figure 10: Chronic Myeloid Leukemia Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Chronic Myeloid Leukemia Patient Flow in UK, 2016
Figure 12: Chronic Myeloid Leukemia Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report